Prevalence and factors associated with tuberculosis infection in India.


Journal

Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 26 06 2023
revised: 29 09 2023
accepted: 03 10 2023
medline: 20 11 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: ppublish

Résumé

The risk of tuberculosis (TB) disease is higher in individuals with TB infection. In a TB endemic country like India, it is essential to understand the current burden of TB infection at the population level. The objective of the present analysis is to estimate the prevalence of TB infection in India and to explore the factors associated with TB infection. Individuals aged > 15 years in the recently completed National TB prevalence survey in India who were tested for TB infection by QuantiFERON-TB Gold Plus (QFT-Plus) assay were considered for this sub-analysis. TB infection was defined as positive by QFT-Plus (value >0.35 IU/ml). The estimates for prevalence, prevalence ratio (PR) and adjusted risk ratio (aRR) estimates with 95% confidence intervals (CIs) were calculated. Of the 16864 individuals analysed, the prevalence of TB infection was 22.6% (95% CI:19.4 -25.8). Factors more likely to be associated with TB infection include age > 30 years (aRR:1.49;95% CI:1.29-1.73), being male (aRR:1.26; 95%CI: 1.18-1.34), residing in urban location (aRR:1.58; 95%CI: 1.03-2.43) and past history of TB (aRR:1.49; 95%CI: 1.26-1.76). About one fourth (22.6%) of the individuals were infected with TB in India. Individuals aged > 30 years, males, residing in urban location, and those with past history of TB were more likely to have TB infection. Targeted interventions for prevention of TB and close monitoring are essential to reduce the burden of TB in India.

Sections du résumé

BACKGROUND BACKGROUND
The risk of tuberculosis (TB) disease is higher in individuals with TB infection. In a TB endemic country like India, it is essential to understand the current burden of TB infection at the population level. The objective of the present analysis is to estimate the prevalence of TB infection in India and to explore the factors associated with TB infection.
METHODS METHODS
Individuals aged > 15 years in the recently completed National TB prevalence survey in India who were tested for TB infection by QuantiFERON-TB Gold Plus (QFT-Plus) assay were considered for this sub-analysis. TB infection was defined as positive by QFT-Plus (value >0.35 IU/ml). The estimates for prevalence, prevalence ratio (PR) and adjusted risk ratio (aRR) estimates with 95% confidence intervals (CIs) were calculated.
RESULTS RESULTS
Of the 16864 individuals analysed, the prevalence of TB infection was 22.6% (95% CI:19.4 -25.8). Factors more likely to be associated with TB infection include age > 30 years (aRR:1.49;95% CI:1.29-1.73), being male (aRR:1.26; 95%CI: 1.18-1.34), residing in urban location (aRR:1.58; 95%CI: 1.03-2.43) and past history of TB (aRR:1.49; 95%CI: 1.26-1.76).
CONCLUSION CONCLUSIONS
About one fourth (22.6%) of the individuals were infected with TB in India. Individuals aged > 30 years, males, residing in urban location, and those with past history of TB were more likely to have TB infection. Targeted interventions for prevention of TB and close monitoring are essential to reduce the burden of TB in India.

Identifiants

pubmed: 37948837
pii: S1876-0341(23)00336-2
doi: 10.1016/j.jiph.2023.10.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2058-2065

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflict of interest to declare.

Auteurs

Sriram Selvaraju (S)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Banurekha Velayutham (B)

ICMR - National Institute for Research in Tuberculosis, Chennai, India. Electronic address: banurekha.vv@icmr.gov.in.

Raghuram Rao (R)

Central TB Division, New Delhi, India.

Kiran Rade (K)

WHO Country Office, New Delhi, India.

Kannan Thiruvengadam (K)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Smita Asthana (S)

ICMR - National Institute of Cancer Prevention and Research, Noida, India.

Rakesh Balachandar (R)

ICMR - National Institute for Occupational Health, Ahmedabad, India.

Sampada Dipak Bangar (SD)

ICMR - National AIDS Research Institute, Pune, India.

Avi Kumar Bansal (AK)

ICMR - National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India.

Jyothi Bhat (J)

ICMR - National Institute of Research in Tribal Health, Jabalpur, India.

Vishal Chopra (V)

Government Medical College, Patiala, India.

Dasarathi Das (D)

ICMR - Regional Medical Research Centre, Bhubaneswar, India.

Shantha Dutta (S)

ICMR - National Institute of Cholera and Enteric Diseases, Kolkata, India.

Kangjam Rekha Devi (KR)

ICMR - Regional Medical Research Centre, Dibrugarh, India.

Gaurav Raj Dwivedi (GR)

ICMR - Regional Medical Research Centre, Gorakhpur, India.

Arshad Kalliath (A)

State TB Cell, Kerala, India.

Avula Laxmaiah (A)

ICMR - National Institute of Nutrition, Hyderabad, India.

Major Madhukar (M)

ICMR - Rajendra Memorial Research Institute of Medical Sciences, Patna, India.

Amarendra Mahapatra (A)

ICMR - Regional Medical Research Centre, Bhubaneswar, India.

Suman Sundar Mohanty (SS)

ICMR - National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India.

Chethana Rangaraju (C)

National Tuberculosis Institute, Bangalore, India.

Jyotirmayee Turuk (J)

ICMR - Regional Medical Research Centre, Bhubaneswar, India.

Pradeep Aravindan Menon (PA)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Rajendran Krishnan (R)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Manjula Singh (M)

Indian Council of Medical Research, New Delhi, India.

Krithikaa Sekar (K)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Aby Robinson (A)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Alka Turuk (A)

Indian Council of Medical Research, New Delhi, India.

Nivethitha N Krishnan (NN)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Nivetha Srinivasan (N)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Catherine Rexy (C)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

M Suresh (M)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Luke Elizabeth Hanna (LE)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

Avijit H Choudhury (AH)

WHO Country Office, New Delhi, India.

Malik Parmar (M)

WHO Country Office, New Delhi, India.

Ranjani Ramachandran (R)

WHO Country Office, New Delhi, India.

Nishant Kumar (N)

Central TB Division, New Delhi, India.

Rajendra Panduranga Joshi (RP)

Central TB Division, New Delhi, India.

Somashekar Narasimhaiah (S)

National Tuberculosis Institute, Bangalore, India.

Padmapriyadarsini Chandrasekaran (P)

ICMR - National Institute for Research in Tuberculosis, Chennai, India.

A M Khan (AM)

ICMR - National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India; Indian Council of Medical Research, New Delhi, India.

Samiran Panda (S)

Indian Council of Medical Research, New Delhi, India.

Balram Bhargava (B)

Indian Council of Medical Research, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH